cyclopentane has been researched along with lucidone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, ST; Kao, YT; Lan, XY; Wang, SY; Xiao, JH; Yang, JC | 1 |
| Senthil Kumar, KJ; Wang, SY | 1 |
| Chang, ST; Chu, FH; Kumar, KJ; Wang, SY; Yang, JC | 1 |
| Hsieh, HW; Senthil Kumar, KJ; Wang, SY | 1 |
| Gokila Vani, M; Liao, JW; Senthil Kumar, KJ; Wang, SY; Xiao, JH | 1 |
| Chen, WC; Chiu, CC; Lee, JC; Lin, CK; Tseng, CK; Wang, HC; Wang, SY | 1 |
| Hsieh, YH; Wang, SY | 1 |
| Chang, SH; Chen, SC; Chou, CW; Hseu, YC; Hung, PC; Kumar, KJ; Lo, HW; Shen, PC; Tsai, YC; Wang, HM; Wang, SY; Yang, HL | 1 |
| Chen, WC; Chen, YH; Hsu, SH; Hung, LC; Lee, JC; Lin, CK; Tseng, CK; Wang, SN; Wang, WH; Wu, YH | 1 |
| Chen, SY; Chen, YY; Hong, CJ; Hsu, YH; Wang, SY; Yen, GC | 1 |
10 other study(ies) available for cyclopentane and lucidone
| Article | Year |
|---|---|
Antiinflammatory activity of Lindera erythrocarpa fruits.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Croton Oil; Cyclopentanes; Dose-Response Relationship, Drug; Edema; Fruit; Inflammation; Lindera; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred ICR; Molecular Structure; Nitric Oxide; Phytotherapy; Plant Extracts | 2008 |
Lucidone inhibits iNOS and COX-2 expression in LPS-induced RAW 264.7 murine macrophage cells via NF-kappaB and MAPKs signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Cell Culture Techniques; Cyclooxygenase 2 Inhibitors; Cyclopentanes; Dinoprostone; Gene Expression; JNK Mitogen-Activated Protein Kinases; Lindera; Lipopolysaccharides; Macrophages; Male; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; NF-kappa B p50 Subunit; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Protein Transport; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2009 |
Lucidone, a novel melanin inhibitor from the fruit of Lindera erythrocarpa Makino.
Topics: Agaricales; Animals; Cyclopentanes; Gene Expression Regulation; Lindera; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
Anti-inflammatory effect of lucidone in mice via inhibition of NF-kappaB/MAP kinase pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Blotting, Western; Cyclooxygenase 2 Inhibitors; Cyclopentanes; Dinoprostone; Electrophoretic Mobility Shift Assay; I-kappa B Kinase; Inflammation; Lindera; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2010 |
Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Cyclopentanes; Ethanol; Heme Oxygenase-1; Hep G2 Cells; Humans; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Protective Agents; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation | 2012 |
Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.
Topics: Antiviral Agents; Biliverdine; Carrier Proteins; Cell Line, Tumor; Cyclopentanes; Drug Therapy, Combination; Fruit; Gene Expression Regulation; Heme Oxygenase-1; Hepacivirus; Hepatocytes; Host-Pathogen Interactions; Humans; Intracellular Signaling Peptides and Proteins; Lindera; NF-E2-Related Factor 2; Protease Inhibitors; Replicon; RNA, Small Interfering; Viral Load; Viral Nonstructural Proteins; Virus Replication | 2013 |
Lucidone from Lindera erythrocarpa Makino fruits suppresses adipogenesis in 3T3-L1 cells and attenuates obesity and consequent metabolic disorders in high-fat diet C57BL/6 mice.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue; Animals; Anti-Obesity Agents; Cell Count; Cyclopentanes; Diet, High-Fat; Dose-Response Relationship, Drug; Fruit; Gene Expression Regulation; Glucose Transporter Type 4; Lindera; Liver; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Orphan Nuclear Receptors; Phytotherapy; PPAR gamma; Transcription, Genetic | 2013 |
Lucidone protects human skin keratinocytes against free radical-induced oxidative damage and inflammation through the up-regulation of HO-1/Nrf2 antioxidant genes and down-regulation of NF-κB signaling pathway.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Cell Nucleus; Cell Survival; Cyclopentanes; DNA Damage; Ethnopharmacology; Fruit; Gene Silencing; Heme Oxygenase-1; Humans; Keratinocytes; Lindera; Lipid Peroxidation; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Protein Transport; Reactive Oxygen Species; Signal Transduction; Taiwan | 2013 |
Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Cyclopentanes; Dengue; Dengue Virus; Disease Models, Animal; Heme Oxygenase-1; Mice, Inbred ICR; NF-E2-Related Factor 2; Survival Analysis; Treatment Outcome; Virus Replication | 2018 |
Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cyclopentanes; HMGB1 Protein; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Signal Transduction | 2022 |